Company news

Bluenergies Ltd. news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

Assemblee generale des actionnaires - BELLUS Sante fait le point sur les progres de l'entreprise et de sa situation financiere

June 4, 2009

Annual General Meeting of Shareholders - BELLUS Health provides updates on corporate and financial developments

June 4, 2009

Assemblee annuelle des actionnaires de BELLUS Sante inc. le 4 juin 2009

June 2, 2009

BELLUS Health Inc. Annual General Meeting of Shareholders June 4, 2009

June 2, 2009

BELLUS Health reports results for first quarter of fiscal 2009

May 6, 2009

BELLUS announces Chief Financial Officer to depart effective May 22, 2009

April 24, 2009

BELLUS Health inc. announces completion of first tranche of financing

April 16, 2009

Bellus Health Inc. provides an update on the financing and the restructuring of existing notes

April 8, 2009

BELLUS Health Inc. provides financing update and announces restructuring of existing notes

March 31, 2009

BELLUS Sante Inc. fait une mise au point concernant son financement

March 24, 2009

BELLUS Health provides financing update

March 24, 2009

BELLUS Sante annonce des reductions de personnel afin de reduire ses frais d'exploitation

March 12, 2009

BELLUS Health announces staff reductions to lower operating expenses

March 12, 2009

BELLUS Health reports results for the fourth quarter of 2008

February 26, 2009

BELLUS Health announces formal notice to voluntarily delist from NASDAQ

December 17, 2008

BELLUS Health is Preparing to Voluntarily Delist from the NASDAQ Capital Market

December 5, 2008

BELLUS Health Announces Stock Listing Transfer from NASDAQ Global Market to NASDAQ Capital Market

November 13, 2008

BELLUS Health Reports Results for Third Quarter of Fiscal 2008 and on EMEA Update

November 10, 2008

BELLUS Health to present at the Rodman and Renshaw 10th Annual Healthcare Conference

November 6, 2008

BELLUS Health provides update on activities

October 21, 2008

BELLUS Health Receives Nasdaq Deficiency Notice Relating to Market Value

October 15, 2008

VIVIMIND(TM), Canada's scientifically proven natural health product to protect memory function, is available starting today

September 2, 2008

Correction from source - BELLUS Health

August 12, 2008

BELLUS Health moves forward on nutraceutical and pharmaceutical fronts - Reports Results for First Half of 2008

August 5, 2008

BELLUS Health announces closing of Innodia acquisition

July 17, 2008

BELLUS Health signs agreement to acquire Innodia

July 16, 2008

BELLUS Health to present at the Rodman and Renshaw 5th Annual Global Healthcare Conference

May 15, 2008

BELLUS HEALTH reports results for first quarter of fiscal 2008

May 5, 2008

At Annual and Special Meeting of Shareholders - Neurochem to officially adopt new name - BELLUS Health - And to provide update on programs including first new natural health product, VIVIMIND(TM)

April 15, 2008

Media advisory - Neurochem's Annual and Special Meeting of Shareholders April 15, 2008

April 11, 2008

Neurochem Annual and Special Meeting of shareholders

April 11, 2008

Neurochem moves eprodisate (KIACTA(TM)) drug development program forward for Amyloid A amyloidosis

March 13, 2008

Neurochem announces departure of two members of management team

February 21, 2008

Neurochem reports results for fourth quarter and fiscal year 2007 and important advances on corporate objectives

February 20, 2008

/C O R R E C T I O N from source -- Neurochem Inc./

February 13, 2008

Neurochem to present at 2008 BIO CEO & Investor Conference - Presentation will be Web cast live

February 11, 2008

Neurochem appoints Mr. Gary Schmid as CEO of new nutraceutical business

January 30, 2008

Neurochem to present at JPMorgan Healthcare Conference

January 3, 2008

Neurochem announces European opinion for Eprodisate (KIACTA(TM)) for the treatment of AA amyloidosis

December 14, 2007

Neurochem announces eprodisate (KIACTA(TM)) receives acknowledgement of complete response and is granted Class 2 review

December 6, 2007

Neurochem announces departure of Dr. Philippe Calais, President, Global Business

November 30, 2007

Neurochem announces important initiatives to provide medical and health benefits to patients

November 8, 2007

Neurochem reports results for third quarter of fiscal 2007

November 7, 2007

Neurochem provides information on cash position

August 28, 2007

Neurochem Announces results from Tramiprosate (ALZHEMED(TM)) North American Phase III Clinical Trial

August 26, 2007

Neurochem reports results for second quarter of fiscal 2007

August 9, 2007

Neurochem granted Fast Track designation from U.S. FDA for tramiprosate (ALZHEMED(TM))

July 24, 2007

Neurochem receives approvable letter for eprodisate (KIACTA(TM)) for treatment of AA amyloidosis

July 17, 2007

Neurochem to present at Jefferies Healthcare Conference

June 26, 2007

Tramiprosate (ALZHEMED(TM)) North American Phase III clinical trial progress update

June 22, 2007

← Newer news releases · Older news releases →

Decks